SG Americas Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-60,558
Closed -$6.01M 3566
2019
Q3
$6.01M Sell
60,558
-84,002
-58% -$7.98M 0.05% 396
2019
Q2
$13.4M Sell
144,560
-107,152
-43% -$10.2M 0.09% 199
2019
Q1
$23.7M Buy
251,712
+20,679
+9% +$1.81M 0.22% 93
2018
Q4
$14.8M Sell
231,033
-288,276
-56% -$21.3M 0.13% 140
2018
Q3
$46.5M Buy
519,309
+13,844
+3% +$1.22M 0.34% 45
2018
Q2
$40.1M Buy
505,465
+326,238
+182% +$27.1M 0.36% 50
2018
Q1
$16M Buy
179,227
+99,726
+125% +$9.57M 0.13% 128
2017
Q4
$8.3M Buy
79,501
+26,562
+50% +$3M 0.08% 226
2017
Q3
$7.72M Buy
52,939
+49,317
+1,362% +$6.72M 0.07% 217
2017
Q2
$470K Sell
3,622
-137,116
-97% -$16.8M ﹤0.01% 1902
2017
Q1
$17.5M Buy
140,738
+24,714
+21% +$2.96M 0.15% 126
2016
Q4
$13.4M Buy
116,024
+24,539
+27% +$2.73M 0.11% 164
2016
Q3
$9.56M Buy
91,485
+12,907
+16% +$1.4M 0.1% 182
2016
Q2
$7.75M Sell
78,578
-177,883
-69% -$18.4M 0.06% 267
2016
Q1
$25.7M Sell
256,461
-301,050
-54% -$31M 0.19% 81
2015
Q4
$66.8M Sell
557,511
-469,644
-46% -$54.3M 0.47% 31
2015
Q3
$41.2M Buy
1,027,155
+242,129
+31% +$30M 0.25% 74
2015
Q2
$90.9M Sell
785,026
-1,131,209
-59% -$129M 0.6% 26
2015
Q1
$221M Buy
1,916,235
+1,297,802
+210% +$155M 1.31% 7
2014
Q4
$69.2M Sell
618,433
-225,484
-27% -$23.8M 0.34% 59
2014
Q3
$80M Sell
843,917
-205,026
-20% -$18.5M 0.47% 38
2014
Q2
$90.1M Sell
1,048,943
-95,613
-8% -$7.27M 0.52% 30
2014
Q1
$79.9M Buy
1,144,556
+207,768
+22% +$16.5M 0.35% 57
2013
Q4
$79.1M Sell
936,788
-308,718
-25% -$24.4M 0.33% 62
2013
Q3
$95.9M Buy
1,245,506
+231,870
+23% +$16.2M 0.39% 54
2013
Q2
$59.3M Buy
+1,013,636
New +$61M 0.29% 72

Other funds holding CELG

SG Americas Securities's CELG Position: Q4 2019 in Review

SG Americas Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 60,558 shares — an estimated $6.01M sold.

SG Americas Securities first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $221M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • SG Americas Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • SG Americas Securities sold 60,558 Celgene Corp shares in Q4 2019, an estimated $6.01M.
  • SG Americas Securities first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • SG Americas Securities's Celgene Corp position peaked at $221M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SG Americas Securities's 13F filing for Q4 2019, filed 28 Jan 2020.